TG(18:0/38:6)
|
Basic information |
| Metabolite name | TG(18:0/38:6) |
 | N/A |
 |
C00422 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | TG(18:0/38:6) |
| N/A |
|
C00422 |
|
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between TG(18:0/38:6) and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Up |
| Study M909 | Type3 | hydroxynorketamine group vs. control group | Plasma | CD-1 mouse | Down |